Zegerid + Prilosec OTC™ Tablets
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Intragastric Acidity
Conditions
Intragastric Acidity
Trial Timeline
Dec 1, 2008 → Mar 1, 2009
NCT ID
NCT01077076About Zegerid + Prilosec OTC™ Tablets
Zegerid + Prilosec OTC™ Tablets is a phase 3 stage product being developed by Bayer for Intragastric Acidity. The current trial status is completed. This product is registered under clinical trial identifier NCT01077076. Target conditions include Intragastric Acidity.
Hype Score Breakdown
Clinical
17
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01077076 | Phase 3 | Completed |